Clinical Trials: Find a Clinical Trial

At any time Memorial Sloan Kettering Cancer Center is conducting hundreds of clinical trials to improve care for many types of cancer. Use the tool below to browse our clinical trials that are currently enrolling new patients. Each listing explains the purpose of the trial, the trial’s eligibility criteria, and how to get more information.

The list below includes clinical trials for adult cancers. Please visit our pediatric cancer care section to find a pediatric clinical trial.

Showing 381 - 400 of 490 trials
Title Investigatorsort icon Disease(s)
Coping with Cancer II
[Protocol 14-048]
Epstein, Andrew
  • Colorectal Cancer
    • Colon Cancer
    • Rectal Cancer
  • Hepatobiliary
    • Liver Cancer
  • Upper Gastrointestinal
    • Esophageal Cancer
    • Gastric Cancer
    • Pancreatic Cancer
A Phase III Study of Neo-Adjuvant Docetaxel and Androgen Deprivation Prior to Radical Prostatectomy versus Immediate Radical Prostatectomy in Patients with High-Risk, Clinically Localized Prostate Cancer
[Protocol 07-041]
Eastham, James
  • Prostate Cancer
    • Localized Disease
A Phase I Study of p28 in Children with Recurrent or Progressive Brain Tumors
Relapsed/Refractory
[Protocol 13-207]
Dunkel, Ira
  • Pediatric Brain Tumors
    • Brain Cancer
A Phase III Study of Multimodality Therapy for Extra-ocular Retinoblastoma
[Protocol 08-072]
Dunkel, Ira
  • Retinoblastoma
A Phase I Study of Single Agent Perifosine for Recurrent Pediatric Solid Tumors
[Protocol 08-091]
Dunkel, Ira
  • Pediatric Brain Tumors
    • Brain Cancer
Neuropsychological, Social, Emotional, and Behavioral Outcomes in Children with Cancer (ALTE07C1)
Newly Diagnosed
[Protocol 12-241]
Dunkel, Ira
  • Survivorship
A Phase II Study of Ipilimumab in Children and Adolescents with Stage III/IV Inoperable Melanoma
Newly Diagnosed & Relapsed/Refractory
[Protocol 13-043]
Dunkel, Ira
  • Melanoma
A Phase I Study of AZD6244 in Pediatric Patients with Recurrent or Refractory Low-Grade Glioma (PBTC-029)
Relapsed/Refractory
[Protocol 12-151]
Dunkel, Ira
  • Pediatric Brain Tumors
    • Brain Cancer
A Phase II Study of Response-Based Radiation Therapy for Patients with Localized Germ Cell Tumors of the Central Nervous System
[Protocol 12-243]
Dunkel, Ira
  • Germ Cell Tumors
  • Pediatric Brain Tumors
    • CNS Cancer
A Phase I Study of Lurbinectedin plus Paclitaxel in Patients with Advanced Solid Tumors
[Protocol 13-170]
Drilon, Alexander
  • Breast Cancer
  • Cervical Cancer
  • Germ Cell Tumors
  • Head & Neck Cancer
  • Lung Cancer
  • Ovarian Cancer
  • Solid Tumors
  • Uterine (Endometrial) Cancer
A Phase II Study of Cabozantinib in Patients with Advanced Non-Small Cell Lung Cancer
[Protocol 12-097]
Drilon, Alexander
  • Lung Cancer
  • Lung Cancer, Non-Small Cell
    • Lung Adenocarcinoma
A Phase I Study of SNX-5422 in Patients with Advanced Lung Cancer
[Protocol 13-230]
Drilon, Alexander
  • Lung Cancer, Non-Small Cell
  • Lung Cancer, Small Cell
A Phase II Study of a Pediatric-Inspired Combination Chemotherapy Regimen in Adults with Acute Lymphoblastic Leukemia
[Protocol 12-266]
Douer, Dan
A Phase I Study of BMS-906024 in Adult and Pediatric Patients with Relapsed/Refractory T-Cell Acute Lymphoblastic Leukemia or T-Cell Lymphoblastic Lymphoma
Relapsed/Refractory
[Protocol 11-181]
Douer, Dan
  • Leukemia
    • Acute Lymphoblastic Leukemia
  • Lymphoma
    • Non-Hodgkin's Lymphoma
A Pilot Trial of Bortezomib in Patients with Relapsed/Refractory AIDS-associated Kaposi Sarcoma
[Protocol 10-117]
Dickson, Mark
  • AIDS-Associated Cancers
    • AIDS-Associated Kaposi's Sarcoma
A Phase I Study of SAR405838 in Patients with Advanced Cancer
[Protocol 13-093]
Dickson, Mark
  • Sarcomas
  • Solid Tumors
A Phase II Study of MLN8237 in Advanced or Metastatic Sarcoma
[Protocol 12-194]
Dickson, Mark
  • Sarcomas
    • Soft Tissue Sarcoma
A Phase II Study of Fulvestrant Alone or with GDC-0941 or GDC-0980 in Women with Advanced Breast Cancer Resistant to Aromatase Inhibitor Therapy
[Protocol 12-029]
Dickler, Maura
  • Breast Cancer
Two Studies of GDC-0032: A Phase I Study of GDC-0032 for Solid Tumors with Increased PI3K Activity, and a Phase II Study of GDC-0032 with Fulvestrant in Patients with Advanced Breast Cancer
[Protocol 13-149]
Dickler, Maura
  • Breast Cancer
A Phase III Study of BKM120 with Fulvestrant in Postmenopausal Women with Locally Advanced or Metastatic Hormone Receptor-Positive HER2-Negative Breast Cancer
[Protocol 12-290]
Dickler, Maura
  • Breast Cancer